- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02096146
TMT Fusion Plate vs. Two Crossed Screws (TMT)
TMT Fusion Plate vs. Two Crossed Screws - A Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Tarsometatarsal joint arthrodesis is a common procedure which can be performed using various devices such as screws, plates or both. The Tarsometatarsal Fusion Plate from "DePuySynthes" is a new device designed to encourage bony fusion of the 1st TMT joint, and is expected to lead to earlier fusion compared to the current standard of care of using 2 crossed screws. This is expected, in turn, to result in an earlier reduction in pain and an earlier return to full activity. At this time there is insufficient data directly comparing outcome following surgery for patients treated with screws or plates, and a study protocol which produces a higher level of evidence is therefore necessary.
The main aim of this study is to compare patient-reported outcome following surgery for patients undergoing joint arthrodesis using the TMT Fusion plate versus screws only. It is expected that surgery will improve patient-reported outcome similarly for both treatment groups in the long-term, but that the improvement will occur earlier for the plate group. For this study patient-reported outcome will be assessed by the walking/standing and pain domain scores of the Manchester Oxford Foot Questionnaire (MOXFQ). An earlier improvement in any of these two domains would be considered to be valuable. The primary analysis will therefore compare the time to a minimal clinically relevant improvement for any of the two MOXFQ domains for patients treated with TMT fusion plate versus patients treated with only screws during the first 12 months following surgery.
An economic evaluation from a societal perspective will determine the incremental cost-effectiveness of the TMT fusion plate versus the 2 crossed screws technique for 1st TMT joint fusion. Therefore a randomized controlled trial will be conducted, where patient-reported outcomes as well as clinical outcome parameters will be assessed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cali, Colombia, 233
- Centro Médico Imbanaco Cali
-
-
-
-
-
Bristol, United Kingdom, BS10 5NB
- Ian Winson
-
-
-
-
Michigan
-
East Lansing, Michigan, United States, 48823
- Mid Michigan Orthopedic Institute - East Lansing
-
-
Minnesota
-
Woodbury, Minnesota, United States, 55125
- Summit Orthopedics
-
-
New York
-
New York, New York, United States, 10038
- NY Downtown Orthopedic Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: between 18 and 65 years
At least one of the following:
- 1st TMT arthritis
- hallux valgus (intermetatarsal angle (IM) 1-2 angle > 15° on plain x-ray)
- 1st ray hypermobility with or without flat foot
- Painful condition
- Ability to understand the content of the patient information / Informed Consent Form
- Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
- Signed and dated IRB/EC-approved written informed consent
Exclusion Criteria:
- Active infection
- Previous surgery on the 1st ray of the same foot
- Previous non-union on the 1st ray of the same foot
- Clinical obvious arthritis in other joints of the lower extremities
- Purely seeking plastic surgery
- Peripheral vascular disease (e.g. advanced diabetes)
- Peripheral sensory neuropathy (e.g. advanced diabetes)
- Concurrent surgery of the contralateral foot
- Any previously medically unmanaged severe systemic disease
- Substance abuse that would preclude reliable assessment
- Prisoner
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: TMT Fusion Plate
Patients are treated with TMT Fusion Plate to encourage bony fusion of the 1st TMT joint.
|
Patients are treated with TMT Fusion Plate a post-market device to encourage bony fusion of the 1st TMT joint.
|
Other: Two crossed screws
Patients are treated with two crossed screws.This procedure is a standard treatment for 1st TMT joint fusion .
|
Patients are treated with two crossed screws.This procedure is a standard treatment for 1st TMT joint fusion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the patient-reported MOXFQ
Time Frame: Up to 4 weeks pre-operative, Discharge (up to 1 week post-operative), 2 week FU, 6 week FU, 3 month FU, 6 month FU, 12 month FU
|
Outcome measures for the study focus on fully validated patient related outcome measures for the foot (MOXFQ).
|
Up to 4 weeks pre-operative, Discharge (up to 1 week post-operative), 2 week FU, 6 week FU, 3 month FU, 6 month FU, 12 month FU
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Development of bone healing assessed based on x-rays
Time Frame: 6 and 12 weeks postoperative
|
6 and 12 weeks postoperative
|
|
Reconstruction of the joint position based on x-rays
Time Frame: Pre-operative up to 4 weeks vs. post-operative up to 2 weeks
|
Pre-operative up to 4 weeks vs. post-operative up to 2 weeks
|
|
Change in quality of life (EQ-5D)
Time Frame: Up to 4 weeks pre-operative, discharge (up to 1 week post-op), 2 weeks FU, 6 weeks FU, 3 months FU, 6 months FU, 12 months FU
|
Outcome measure of general health
|
Up to 4 weeks pre-operative, discharge (up to 1 week post-op), 2 weeks FU, 6 weeks FU, 3 months FU, 6 months FU, 12 months FU
|
Weekly assessed weight bearing during weeks 6-12
Time Frame: 3 months FU
|
3 months FU
|
|
Complications related to implant or surgery
Time Frame: Starts with surgery and is continued until the end of the study (12 months FU)
|
For the duration of the study complications are continuously recorded and not restricted to the defined follow up visits.
|
Starts with surgery and is continued until the end of the study (12 months FU)
|
Documentation of medication and treatment costs
Time Frame: Starts after surgery and is continued until the end of the study (12 months FU)
|
A cost diary to collect treatment costs is distributed and collected at the next FU visit.
|
Starts after surgery and is continued until the end of the study (12 months FU)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ian Winson, MB ChB, FRCS, Southmead Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TMT Fusion Plate
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical Indication for First Metatarsal Joint Arthrodesis
-
GE HealthcareICON plcCompletedClinical Indication for Brain MRIUnited States
-
GE HealthcareCompletedClinical Indication for a Head MRIUnited States
-
GE HealthcareCompletedSubjects With Clinical Indication for PET/CTSwitzerland
-
GE HealthcareCompletedAny Condition With a Clinical Indication for PET/CT ExamUnited States
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
Centre Hospitalier Universitaire DijonCompletedHip Osteoarthritis | Indication for Total Hip ReplacementFrance
-
Arthrex, Inc.RecruitingHyperpronated Foot | Reconstruction Surgeries of the Foot | Fixation of Fractures and Fusion (Bunionectomy Osteotomies) of the Foot/Ankle | Fixation of Small Bone Fragments of the Foot/Ankle | Lisfranc Arthrodesis | Mono or Bi-cortical Osteotomies in the Forefoot | First Metatarsophalangeal Arthrodesis and other conditionsGermany, United States, South Africa
Clinical Trials on TMT Fusion plate
-
Oslo University HospitalCompleted
-
Medtronic Spinal and BiologicsCompletedRadiculopathy | Myelopathy | Cervical Degenerative Disc DiseaseUnited States
-
Medtronic Spinal and BiologicsCompletedRadiculopathy | Myelopathy | Cervical Degenerative Disc DiseaseUnited States
-
Seoul National University HospitalCompletedDegenerative Disease | Cervical Vertebrae | SingleKorea, Republic of
-
Seoul National University HospitalKorean Society of Spine SurgeryActive, not recruitingMyelopathy | Radiculopathy, CervicalKorea, Republic of
-
Beijing Friendship HospitalUnknown
-
DePuy SpineCompletedCervical Degenerative Disc DiseaseUnited States, Netherlands, Australia
-
National Institute of Allergy and Infectious Diseases...Atopic Dermatitis Research NetworkCompleted
-
Medtronic Spinal and BiologicsCompleted
-
Rigshospitalet, DenmarkZimmer BiometActive, not recruiting